ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,364,061 | -10.7% | 65,454 | +2.6% | 0.01% | -16.7% |
| Q2 2023 | $1,527,268 | +10081.8% | 63,769 | +5967.5% | 0.01% | – |
| Q2 2022 | $15,000 | -71.7% | 1,051 | -51.9% | 0.00% | – |
| Q1 2022 | $53,000 | +8.2% | 2,184 | +4.9% | 0.00% | – |
| Q4 2021 | $49,000 | +250.0% | 2,081 | +156.0% | 0.00% | – |
| Q3 2021 | $14,000 | -74.1% | 813 | -62.9% | 0.00% | -100.0% |
| Q2 2021 | $54,000 | -18.2% | 2,194 | -13.7% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | -30.5% | 2,543 | +42.5% | 0.00% | 0.0% |
| Q4 2020 | $95,000 | +1087.5% | 1,785 | +1090.0% | 0.00% | – |
| Q2 2020 | $8,000 | -11.1% | 150 | -57.1% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +50.0% | 350 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -60.0% | 350 | -51.2% | 0.00% | -100.0% |
| Q3 2018 | $15,000 | 0.0% | 717 | -29.4% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | +66.7% | 1,015 | +125.6% | 0.00% | 0.0% |
| Q1 2018 | $9,000 | -47.1% | 450 | -18.2% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | +70.0% | 550 | +57.1% | 0.00% | – |
| Q3 2017 | $10,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |